Popular drug withdrawn from Polish pharmacies: Check if you have it at home
The Chief Pharmaceutical Inspector has decided to immediately withdraw one batch of a popular drug used by patients in Poland from the market. This decision is precautionary and stems from the detection of a quality defect that may pose a risk to the health of those taking the preparation.
The problem concerns a specific batch of the product in which non-compliance with safety standards was identified. The drug manufacturer has been ordered to withdraw the defective batch from all pharmacies and wholesalers across the country. Information regarding the batch number subject to the sales ban has already been published in an official statement by the authority.
Experts emphasize that patients who have the drug from this specific batch in their home medicine cabinets should not take it. Those who have already taken the preparation should monitor their health and, in the event of any worrying symptoms, consult a doctor or pharmacist. The withdrawn product can be returned to a pharmacy, where it will be disposed of.
Decisions to withdraw drugs from the market are made regularly in Poland to ensure patient safety. These situations are monitored by the appropriate services, which ensure that only products meeting rigorous pharmaceutical standards reach the market. It is worth checking the announcements published by the Chief Pharmaceutical Inspectorate regularly to stay up to date with information regarding drug safety.